FDA Approves Blood-Based Prostate Cancer Test
The test receives premarket approval as an aid in biopsy decision-making for men 50 and older with elevated PSA levels.
Category: Prostate
Prostate
Latest
Prostate
Latest
Landmark Longitudinal Prostate Cancer Study Released
A new study confirms Cleveland Diagnostics’ IsoPSA test effectively differentiates between low- and high-risk prostate cancer patients.
Prostate
Latest
Early Blood Test Predicts Survival in Patients with Metastatic Prostate Cancer
A study shows that measuring CTCs at the time of metastatic prostate cancer diagnosis can predict survival and guide treatment decisions.
Prostate Cancer Risks for Transgender Women on Hormone Therapy
A study warns that transgender women on hormone therapy may have artificially low PSA levels, potentially delaying prostate cancer diagnosis.
Read More
New Urine Test Detects High-Grade Prostate Cancer
The new urine-based test aims to differentiate between slow-growing and aggressive forms of prostate cancer.
Read More
Blood Test Could Improve Active Surveillance for Prostate Cancer
A study found an active surveillance blood test for prostate cancer could predict whether a patient had indolent or aggressive disease.
Read More
Prostate Cancer Screening with a PSA Test Leads to OverdiagnosisÂ
A study investigating a single invitation to a PSA blood test to screen for prostate cancer found it had a small impact on reducing deaths.
Read More
Blood Test and MRI Combo Could Reduce Unnecessary Prostate Biopsies
MRI of the prostate, combined with a blood test, can help find if a prostate lesion is clinically significant cancer, new research suggests.
Read More
Researchers Use Deep Learning to Diagnose Prostate Cancer
Researchers developed a deep-learning model to improve the 3D segmentation of glandular tissue structures for prostate cancer assessment.
Read More
AI Reveals Prostate Cancer is Not Just One Disease
AI has helped scientists reveal a new form of aggressive prostate cancer which could revolutionize how the disease is diagnosed in the future.Â
Read More
Oncobiomix Adopts AI-Based Disease Insights Platform for Prostate Cancer Test
Oncobiomix says it will use Limmi’s Disease Insights Platform to power their AI models for predicting prostate cancer risk.
Read More
AI Algorithm Promises to Improve Workflows at Ohio Cancer Center
Pathologists at OSUCCC-James have been evaluating an AI algorithm for the past year. The results are extremely promising.
Read More
Rectal Examinations Do Not Improve Prostate Cancer Screening Effectiveness
A new study has found that rectal examination has no advantages over the PSA blood test for detecting prostate cancer.
Read More
Blood Test Distinguishes Neuroendocrine Subtype of Advanced Prostate Cancer
Researchers have developed a blood test that can reliably detect NEPC and differentiate it from CRPC-adenocarcinoma.
Read More
ArteraAI Gets Medicare Payment Rate for Prostate Cancer Test
ArteraAI says the CMS decided on the payment rate for the ArteraAI Prostate Test, a clinical diagnostic laboratory test for prostate cancer.
Read More
$3M Grant to Develop AI to Detect Aggressive Prostate Cancer
UCLA Researchers have received a five-year, $3 million grant to develop AI that can detect and predict aggressive prostate cancer.
Read More
Biomarker HSD3B1 Identified as Reason for Therapeutic Resistance
Men with biomarker HSD3B1 may exhibit resistance to combined radiation and hormone therapy for prostate cancer.Â
Read More
Black Men are More Likely to Have Prostate Cancer than White Men
Black men are more likely to develop prostate cancer than white men and more likely to have advanced disease and to die than white men.Â
Read More